FLT3 and acute myeloid leukemia: Prevalence was similar across the higher risk genetic categories for HLADR-low subpopulations; however 60% of relapses in patients with MDS-like mutations had a rapid expansion of LSC-like subpopulations compared to 32% with FLT3-ITD mutated AML.